14020 Federal Register / Vol. 87, No. 48 / Friday, March 11, 2022 / Notices 

1West, C.P., Dyrbye, L.N., Satele, D.V, Sloan, J.A., 

& Shanafelt, T.D. (2012). Concurrent validity of 

single-item measures of emotional exhaustion and 

depersonalization in burnout assessment. J Gen 

Intern Med, 27 (11 PG–1445–52), 1445–1452. 

https://doi.org/10.1007/s11606-012-2015-7. 

low sense of personal accomplishment 

at work.1 Understanding the factors 

impacting workforce well-being and 

satisfaction, reducing burnout, and 

applying evidence-based technical 

assistance and other quality 

improvement strategies around 

workforce well-being is essential as the 

health center program health care 

workforce continues to respond to and 

recover from the COVID–19 pandemic 

and prepare for future health care 

delivery challenges. 

Administration of the Health Center 

Workforce Survey will provide a 

comprehensive baseline assessment of 

health center workforce well-being and 

identify opportunities to improve 

workforce well-being and bolster 

technical assistance and other strategies. 

These efforts will further HRSA’s goal of 

providing access to quality health care 

and supporting a robust primary care 

workforce. 

Likely Respondents: Health center 

staff in HRSA-funded health centers. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Health Center Workforce Survey ......................................... 400,000 1 400,000 .50 200,000 

Health Center Leader Support Activities ............................. 1,400 1 1,400 2.00 2,800 

401,400 ........................ 401,400 ........................ 202,800 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–05077 Filed 3–10–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Vaccine Injury Compensation 

Program: Revised Amount of the 

Average Cost of a Health Insurance 

Policy 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HRSA is publishing an 

updated monetary amount of the 

average cost of a health insurance policy 

as it relates to the National Vaccine 

Injury Compensation Program (VICP). 

FOR FURTHER INFORMATION CONTACT: 

George Reed Grimes, Director, Division 

of Injury Compensation Programs, 

Health Systems Bureau, HRSA, HHS by 

mail at 5600 Fishers Lane, 08N186B, 

Rockville, Maryland 20857; call 1–800– 

338–2382 or email 

vaccinecompensation@hrsa.gov. 

SUPPLEMENTARY INFORMATION: Section 

100.2 of the VICP’s implementing 

regulation (42 CFR part 100) states that 

the revised amount of an average cost of 

a health insurance policy, as determined 

by the Secretary of HHS (the Secretary), 

is effective upon its delivery by the 

Secretary to the United States Court of 

Federal Claims (the Court), and will be 

published periodically in a notice in the 

Federal Register. The Secretary 

delegated this responsibility to the 

HRSA Administrator. This figure is 

calculated using the most recent 

Medical Expenditure Panel SurveyInsurance Component (MEPS–IC) data 

available as the baseline for the average 

monthly cost of a health insurance 

policy. This baseline is adjusted by the 

annual percentage increase/decrease 

obtained from the most recent annual 

Kaiser Family Foundation (KFF) 

Employer Health Benefits Survey or 

other authoritative sources that may be 

more accurate or appropriate. 

In 2021, MEPS–IC, available at 

www.meps.ahrq.gov, published the 

annual 2020 average total single 

premium per enrolled employee at 

private-sector establishments that 

provide health insurance. The figure 

published was $7,149. This figure is 

divided by 12 to determine the cost per 

month of $595.75. The $595.75 figure is 

increased or decreased by the 

percentage change reported by the most 

recent KFF Employer Health Benefits 

Survey, available at www.kff.org. The 

increase from 2020 to 2021 was 4.0 

percent. By adding this percentage 

increase, the calculated average monthly 

cost of a health insurance policy for a 

12-month period is $619.58. 

Therefore, the revised average cost of 

a health insurance policy under the 

VICP is $619.58 per month. In 

accordance with § 100.2, the revised 

amount was effective upon its delivery 

to the Court. 

Carole Johnson, 

Administrator. 

[FR Doc. 2022–05220 Filed 3–10–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 48 / Friday, March 11, 2022 / Notices 14021 

ACTION: Notice. 

SUMMARY: Findings of research 

misconduct have been made against 

Terry Magnuson, Ph.D. (Respondent), 

Kay M. & Van L. Weatherspoon Eminent 

Distinguished Professor, Department of 

Genetics, School of Medicine (SOM), 

University of North Carolina at Chapel 

Hill (UNC). Respondent engaged in 

research misconduct in research 

included in one (1) grant application for 

U.S. Public Health Service (PHS) funds, 

specifically National Cancer Institute 

(NCI), National Institutes of Health 

(NIH), grant application R01 CA267946– 

01A1. The administrative actions, 

including supervision from February 25, 

2022–January 5, 2024, are detailed 

below. 

FOR FURTHER INFORMATION CONTACT: 

Wanda K. Jones, Dr.P.H., Acting 

Director, Office of Research Integrity, 

1101 Wootton Parkway, Suite 240, 

Rockville, MD 20852, (240) 453–8200. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that the Office of Research 

Integrity (ORI) has taken final action in 

the following case: 

Terry Magnuson, Ph.D., University of 

North Carolina at Chapel Hill: Based on 

the report of an assessment conducted 

by UNC, Respondent’s admission, and 

additional analysis conducted by ORI in 

its oversight review, ORI found that Dr. 

Terry Magnuson, Kay M. & Van L. 

Weatherspoon Eminent Distinguished 

Professor, Department of Genetics, 

SOM, UNC, engaged in research 

misconduct in research included in one 

(1) grant application for PHS funds, 

specifically NCI, NIH, grant application 

R01 CA267946–01A1. 

ORI found that Respondent engaged 

in research misconduct by intentionally, 

knowingly, or recklessly plagiarizing 

text from the following three (3) online 

articles and one (1) published paper: 

• Comprehensive Guide to 

Understanding and Using CUT&Tag 

Assay. November 4, 2020. https://

www.activemotif.com/blog-cut-tag 

(hereafter referred as ‘‘Blog cut&tag 

2020’’). 

• Complete Guide to Understanding 

and Using ATAC-Seq. February 9, 2021. 

https://www.activemotif.com/blog-atacseq (hereafter referred as ‘‘Blog ATACSeq 2021’’). 

• Illumina CATCH–IT. https://

www.illumina.com/science/sequencingmethod-explorer/kits-and-arrays/catchit.html (hereafter referred as ‘‘Illumina 

Catch-it’’). 

• Modeling Physiological Events in 

2D vs. 3D Cell Culture. Physiology 

(Bethesda) 2017 Jul;32(4):266–277; doi: 

10.1152/physiol.00036.2016 (hereafter 

referred as ‘‘Physiology (Bethesda) 

2017’’). 

Plagiarized text was included in: 

• Grant application R01 CA267946– 

01A1, ‘‘Genome-wide dynamics of 

chromatin modifiers,’’ submitted to 

NCI, NIH, on March 1, 2021 (hereafter 

referred as ‘‘R01 CA267946–01A1’’) 

Specifically, ORI found that 

Respondent knowingly, intentionally, or 

recklessly plagiarized from: 

• The introduction (p. 266) and 

techniques (p. 267) sections of 

Physiology (Bethesda) 2017 to 

compose subsection ‘‘ii. Identifying 

changes to SWI/SNF composition 

driven by cell state changes’’ of 

Specific Aim 1 of R01 CA267946– 

01A1 

• the introduction and sections ‘‘What 

is CUT&Tag’’ and ‘‘Before CUT&Tag, 

There Was CUT&RUN’’ of Blog 

cut&tag 2020 to compose the ‘‘CHIPseq protocols’’ description in R01 

CA267946–01A1 

• the ‘‘What is ATAC-Seq?’’ section of 

Blog ATAC-Seq 2021 to compose the 

‘‘ATAC-seq protocols’’ description in 

R01 CA267946–01A1 

• the web page ‘‘Illumina Catch-it’’ 

describing the CATCH–IT technology 

to compose the ‘‘Pitfalls & 

Alternatives’’ section of Specific Aim 

1 in R01 CA267946–01A1 

Dr. Magnuson entered into a 

Voluntary Settlement Agreement 

(Agreement) and voluntarily agreed to 

the following: 

(1) Respondent will have his research 

supervised from February 25, 2022– 

January 5, 2024 (the ‘‘Supervision 

Period’’). Prior to the submission of an 

application for PHS support for a 

research project on which Respondent’s 

participation is proposed and prior to 

Respondent’s participation in any 

capacity in PHS-supported research, 

Respondent will submit a plan for 

supervision of Respondent’s duties to 

ORI for approval. The supervision plan 

must be designed to ensure the integrity 

of Respondent’s research. Respondent 

will not participate in any PHSsupported research until such a 

supervision plan is approved by ORI. 

Respondent will comply with the 

agreed-upon supervision plan. 

(2) The requirements for Respondent’s 

supervision plan are as follows: 

i. The respondent will submit his 

grant applications seeking PHS support 

to the Vice Dean, UNC SOM, thirty (30) 

days prior to the grant application 

submission deadline. The SOM Office of 

Research (OR) will review Respondent’s 

grant applications to check for 

plagiarism and ensure compliance with 

acceptable scientific practice for citation 

of prior work. SOM OR will not recruit 

Respondent’s supervisor or 

collaborators to review his grant 

applications. SOM OR will submit a 

report to ORI at six (6) month intervals 

setting forth the committee meeting 

dates and Respondent’s compliance 

with appropriate research standards and 

confirming the integrity of Respondent’s 

research. 

ii. SOM OR will conduct an advance 

review of any report, manuscript, or 

abstract involving PHS-supported 

research in which Respondent is 

involved. The review will include a 

discussion with Respondent of the 

primary data represented in those 

documents and will include a 

certification to ORI that the data 

presented and the text in the report, 

manuscript, or abstract is supported by 

the research record and not plagiarized. 

(3) During the Supervision Period, 

Respondent will ensure that any 

institution employing him submits, in 

conjunction with each application for 

PHS funds, or report, manuscript, or 

abstract involving PHS-supported 

research in which Respondent is 

involved, a certification to ORI that the 

data provided by Respondent are based 

on actual experiments or are otherwise 

legitimately derived and that the data, 

procedures, and methodology are 

accurately reported and not plagiarized 

in the application, report, manuscript, 

or abstract. 

(4) If no supervision plan is provided 

to ORI, Respondent will provide 

certification to ORI at the conclusion of 

the Supervision Period that his 

participation was not proposed on a 

research project for which an 

application for PHS support was 

submitted and that he has not 

participated in any capacity in PHSsupported research. 

Dated: March 8, 2022. 

Wanda K. Jones, 

Acting Director, Office of Research Integrity, 

Office of the Assistant Secretary for Health. 

[FR Doc. 2022–05217 Filed 3–10–22; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Impact of Health Misinformation in the 

Digital Information Environment in the 

United States Throughout the COVID– 

19 Pandemic Request for Information 

(RFI); Correction 

AGENCY: Office of the Surgeon General, 

Department of Health and Human 

Services. 

ACTION: Notice; correction. 


lotter on DSK11XQN23PROD with NOTICES1